Abstract
Purpose
To report the clinical manifestations, identification, antimicrobial susceptibilities, and treatment outcomes of ocular infections caused by Moraxella species.
Study design
Retrospective study.
Patients and methods
The medical records of all patients treated at the Departments of Ophthalmology of the Ogaki Municipal Hospital and the Gifu University Graduate School of Medicine for ocular infections caused by Moraxella species between January 2011 and June 2017 were examined. The stored Moraxella species isolated from ocular samples were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), molecular identification, and the biochemical properties.
Results
Sixteen eyes of 16 patients were treated for Moraxella ocular infections. The patients’ median age was 72 years. A predisposing systemic or ocular condition was identified in 15 of the patients. Nine of the patients developed keratitis; four, conjunctivitis; and three, blebitis. M lacunata (6 eyes), M catarrhalis (6), M nonliquefaciens (3), and M osloensis (1) were identified by MALDI-TOF MS. All isolates were sensitive to levofloxacin, tobramycin, ceftazidime, ceftriaxone, and cefazolin. Twelve patients with keratitis or blebitis were treated with various topical antimicrobial combinations, and systemic antibiotics were used in 10 of the 12 patients. The mean time for the complete closure of the epithelial defects with keratitis was 24 days. The visual outcomes after treatment were favorable except in 1 keratitis patient who underwent enucleation.
Conclusions
The use of duo-therapy with a combination of fluoroquinolone and cefmenoxime should be considered in cases nonresponsive to monotherapy, such as keratitis and bleb-associated infections. MALDI-TOF MS is useful for the identification of Moraxella to the species level.
Similar content being viewed by others
References
Berrocal AM, Scott IU, Miller D, Flynn HW Jr. Endophthalmitis caused by Moraxella species. Am J Ophthalmol. 2001;132:788–90.
Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001;85:842–7.
Berrocal AM, Scott IU, Miller D, Flynn HW Jr. Endophthalmitis caused by Moraxella osloensis. Graefes Arch Clin Exp Ophthalmol. 2002;240:329–30.
Das S, Constantinou M, Daniell M, Taylor HR. Moraxella keratitis: predisposing factors and clinical review of 95 cases. Br J Ophthalmol. 2006;90:1236–8.
Inoue H, Suzuki T, Inoue T, Hattori T, Nejima R, Todokoro D, et al. Clinical characteristics and bacteriological profile of Moraxella keratitis. Cornea. 2015;34:110–9.
Tobimatsu Y, Inada N, Shoji J, Yamagami S. Clinical characteristics of 17 patients with Moraxella keratitis. Semin Ophthalmol. 2018;33:726–32.
Leung AK, Hon KL, Wong AHC, Wong AS. Bacterial conjunctivitis in childhood: etiology, clinical manifestations, diagnosis, and management. Recent Pat Inflamm Allergy Drug Discov. 2018. https://doi.org/10.2174/1872213x12666180129165718.
Varaprasathan G, Miller K, Lietman T, Whitcher JP, Cevallos V, Okumoto M, et al. Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea. 2004;23:360–4.
Cornut PL, Chiquet C, Bron A, Romanet JP, Lina G, Lafontaine PO, FRIENDS Group, et al. Microbiologic identification of bleb-related delayed-onset endophthalmitis caused by Moraxella species. J Glaucoma. 2008;7:541–5.
Jacobs DJ, Leng T, Flynn HW Jr, Shi W, Miller D, Gedde SJ. Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result. Clin Ophthalmol. 2011;5:739–44.
Takahashi H, Fujimura S, Ubukata S, Sato E, Shoji M, Utagawa M, et al. Pneumonia after earthquake, Japan, 2011. Emerg Infect Dis. 2012;18:1909–11.
Dingle TC, Butler-Wu SM. Maldi-tof mass spectrometry for microorganism identification. Clin Lab Med. 2013;33:589–609.
Jabs DA. Improving the reporting of clinical case series. Am J Ophthalmol. 2005;139:900–5.
Masaki T, Ohkusu K, Ezaki T, Miyamoto H. Nocardia elegans infection involving purulent arthritis in humans. J Infect Chemother. 2012;18:386–9.
Pettersson B, Kodjo A, Ronaghi M, Uhlén M, Tønjum T. Phylogeny of the family Moraxellaceae by 16S rDNA sequence analysis, with special emphasis on differentiation of Moraxella species. Int J Syst Bacteriol. 1998;48:75–89.
Orlans HO, Hornby SJ, Bowler IC. In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye (Lond). 2011;25:489–93.
National Surveillance of Infectious Keratitis in Japan. National Surveillance of Infectious Keratitis in Japan: current status of isolates, patient background, and treatment. Nippon Ganka Gakkai Zasshi. 2006;110:961–72 (in Japanese).
Tan SZ, Walkden A, Au L, Fullwood C, Hamilton A, Qamruddin A, et al. Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital. Eye (Lond). 2017;31:1229–36.
Mian SI, Malta JB. Moraxella keratitis: risk factors, presentation, and management. Acta Ophthalmol. 2011;89:e208–9.
Barash A, Chou TY. Moraxella atlantae keratitis presenting with an infectious ring ulcer. Am J Ophthalmol Case Rep. 2017;7:62–5.
Morax V. Note sur un diplobacille pathogène pour la conjonctivite humaine. Ann Inst Pasteur. 1896;10:337–45.
Axenfeld T. Über die chronische Diplobacille conjunctivitis. Zentralbl Bakteriol. 1897;21:1–9.
Cobo LM, Coster DJ, Peacock J. Moraxella keratitis in a nonalcoholic population. Br J Ophthalmol. 1981;65:683–6.
Shah SS, Ruth A, Coffin SE. Infection due to Moraxella osloensis: case report and review of the literature. Clin Infect Dis. 2000;30:179–81.
Dalmon C, Porco TC, Lietman TM, Prajna NV, Prajna L, Das MR, et al. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci. 2012;53:1787–91.
Garg P, Mathur U, Athmanathan S, Rao GN. Treatment outcome of Moraxella keratitis: our experience with 18 cases: a retrospective review. Cornea. 1999;18:176–81.
Suzuki T, Ohashi Y. Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index. Cornea. 2013;32:e156–60.
Laukeland H, Bergh K, Bevanger L. Posttrabeculectomy endophthalmitis caused by Moraxella nonliquefaciens. J Clin Microbiol. 2002;40:2668–770.
Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109:985–91.
Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology. 2004;111:1495–503.
Yamamoto T. Bleb-related infection: clinical features and management. Taiwan J Ophthalmol. 2012;2:2–5.
Hori N, Mochizuki K, Ishida K, Yamamoto T, Mikamo H. Clinical characteristics and risk factors of glaucoma filtering bleb infections. Nippon Ganka Gakkai Zasshi. 2009;113:951–63 (in Japanese).
Nihonyanagi S, Wada T, Adachi Y, Fujimura H, Munekata S, Kanoh Y, et al. Trends in the occurrence and antibiotic susceptibility of Moraxella catarrhalis from 2009 to 2014. Jpn J Med Technol. 2016;65:268–74.
Stull TL, Stanford EJ. Pseudogonococcal ophthalmia neonatorum caused by Branhamella catarrhalis. Pediatr Infect Dis. 1986;5:104–5.
Maruyama Y, Shigemura T, Aoyama K, Nagano N, Nakazawa Y. Bacteremia due to Moraxella osloensis: a case report and literature review. Braz J Infect Dis. 2018;22:60–2.
Hansen W, Butzler JP, Fuglesang JE, Henriksen SD. Isolation of penicillin and streptomycin resistant strains of Moraxella osloensis. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974;82:318–22.
Acknowledgments
We would like to express our gratitude to Mr Haruki Sawamura, PhD, for scientific advice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
S. Takahashi, None; K. Murata, None; K. Ozawa, None; H. Yamada, None; H. Kawakami, None; A. Nakayama, None; Y. Asano, None; K. Mochizuki, None; H. Mikamo, None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Corresponding author: Hideaki Kawakami
About this article
Cite this article
Takahashi, S., Murata, K., Ozawa, K. et al. Moraxella species: infectious microbes identified by use of time-of-flight mass spectrometry. Jpn J Ophthalmol 63, 328–336 (2019). https://doi.org/10.1007/s10384-019-00669-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-019-00669-4